Research Topics
| Joachim HombachSummaryAffiliation: World Health Organization Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Vaccines against dengue: a review of current candidate vaccines at advanced development stagesJoachim Hombach
World Health Organization, Initiative for Vaccine Research, Geneva, Switzerland
Rev Panam Salud Publica 21:254-60. 2007
Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisalRaymond Hutubessy
Initiative for Vaccine Research, Immunization, Biologicals and Vaccines Department, World Health Organization, 20 Avenue Appia, CH 1210 Geneva, Switzerland
BMC Med 9:55. 2011....- Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making toolsNathorn Chaiyakunapruk
Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
BMC Med 9:53. 2011..With the aim to guide policymakers on their optimal use, we compared publicly available decision-making tools in relation to their methods, influential parameters and results... - Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillanceSusan Hills
PATH, Seattle, WA, USA
BMC Infect Dis 9:214. 2009..To aid acceptance of the Standards, we describe the process of development, provide the supporting evidence, and explain the rationale for the recommendations made in the document... - Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, ThailandJ Hombach
Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Vaccine 23:2689-95. 2005.... - Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004Joachim Hombach
Immunization, Vaccines and Biologicals, World Health Organization, 20, Geneva 27, Switzerland
Vaccine 23:5205-11. 2005..More detailed recommendations will be drafted following further consultations to serve as WHO guidelines for evaluation and licensure for new JE vaccines... - Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005Joachim Hombach
Initiative for Vaccine Research, World Health Organization, CH 1211 Geneva 27, Switzerland
Vaccine 25:4130-9. 2007..It is concluded that it is not yet possible to define one specific set of correlates, the consultation concluded in recommendations that should help to gather the missing evidence in conjunction with future vaccine trials... 
Guidelines for clinical trials of dengue vaccine in endemic areasJoachim Hombach
Initiative for Vaccine Research, Immunization, Vaccines and Biologicals, Family and Community Health, WHO, Geneva, Switzerland
J Clin Virol 46:S7-9. 2009..These guidelines are primarily aimed at national regulatory authorities, vaccine developers and research scientists and should be analysed, discussed and adjusted where necessary...- A global pandemic influenza vaccine action planMarie Paule Kieny
World Health Organization, Geneva, Switzerland
Vaccine 24:6367-70. 2006..2) To strengthen the engagement and collaboration of key partners and stakeholders... - DengueA Kroeger
Nat Rev Microbiol 2:360-1. 2004 - Dengue research and training supported through the World Health OrganizationA Kroeger
UNICEF UNDP World Bank WHO Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, 1211 Geneva 27, Switzerland
Ann Trop Med Parasitol 100:S97-S101. 2006..This intensified effort, in close collaboration with other stakeholders, is contributing towards the goals of reversing the current epidemiological trends and of reducing the global burden posed by dengue in all of its forms... - Next generation dengue vaccines: a review of candidates in preclinical developmentJulia Schmitz
Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Vaccine 29:7276-84. 2011..This review provides an overview of the various technological approaches to dengue vaccine development and specifically focuses on candidates in preclinical development... - Arguments for live flavivirus vaccinesJoachim Hombach
Lancet 364:498-9. 2004 - "Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical ConsultationRobert Edelman
Department of Medicine and Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA
Vaccine 26:4113-9. 2008.... - Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue VirusesJohn T Roehrig
National Center for Zoonotic, Vector Borne and Enteric Diseases, Centers for Disease Control and Prevention, U S Department of Health and Human Services, Fort Collins, Colorado, USA
Viral Immunol 21:123-32. 2008..A more complete version of these guidelines is available on the WHO website: http://www.who.int/immunization/documents/date/en/index.html...